Mitomycin

CAS 50-07-7 6 current records 2 historicalSmall Molecule

Who holds supplier records for Mitomycin? 6 organisations hold a current record for Mitomycin: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 5 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (2), India (1), Netherlands (1) and France (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Mitomycin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/mitomycin

Reading the evidence

  • 6 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 4 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Mitomycin expires 25 Jul 2044. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (6)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Mitomycin. Country is the organisation's recorded country, not necessarily the manufacturing site.

China2India1Netherlands1France1Country not recorded for 1
  • CONCORD BIOTECH LTD
    Active DMF 33662 · latest filing Apr 2019
    IndiaCEP Company GMP cert on record
  • HUBEI HONCH PHARMACEUTICAL CO LTD
    Active DMF 37462 · latest filing Oct 2023
    CEP Company GMP cert on record
  • TAPI NL BV
    Active DMF 13791 · latest filing Sept 1998
    NetherlandsCEP
  • Wuxi Fortune Pharmaceutical Co., Ltd.
    Active DMF 34866 · latest filing Sept 2020
    ChinaCEP Company GMP cert on record
  • Zhejiang Hisun Pharmaceutical Co., Ltd.
    Active DMF 13783, 25659 · latest filing Dec 2011
    ChinaCEP Company GMP cert on record
  • CHEMWERTH INC
    Active DMF 33811 · latest filing Nov 2019
    France
Need Mitomycin sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (5)

Certificates of Suitability on the EDQM register for Mitomycin, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 7 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
HUBEI HONCH PHARMACEUTICAL CO., LTD. HuanggangCN
CEP 2026-431 - Rev 00
Mitomycin, Process 2
Oct 2026Inspected Feb 2025
Switzerland
CONCORD BIOTECH LIMITED AhmedabadIN
CEP 2019-308 - Rev 01
Mitomycin
Dec 2025Inspected Jul 2025
Germany
TAPI NL B.V. AmsterdamNL
CEP 2007-124 - Rev 05
Mitomycin
Mar 2025—
WUXI FORTUNE PHARMACEUTICAL CO., LTD. WuxiCN
R1-CEP 2016-034 - Rev 00
Mitomycin
Nov 2022—
Zhejiang Hisun Pharmaceutical Co., Ltd. Taizhou CityCN
R1-CEP 2012-013 - Rev 00
Mitomycin, Alternative process
May 2022—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (2)

Organisations whose Type II DMFs for Mitomycin are no longer active. These show a past filing, not current supply.

Show all 2 historical records
  • Japan · Inactive DMF 13785 · filed Sept 1998
  • KYOWA HAKKO KOGYO CO LTD
    Inactive DMF 13521 · filed Sept 1998

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (22 listed products contain Mitomycin). The latest listed patent expires 25 Jul 2044. The latest listed exclusivity runs to 12 Jun 2028. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Mitomycin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL105).

Chemical identity

IUPAC name
[(4S,6S,7R,8S)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate
Canonical SMILES
CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N
InChIKey
NWIBSHFKIJFRCO-WUDYKRTCSA-N
Synonyms
Ametycine, Jelmyto, Mitocin-c, Mitomicina, Mitomycin, Mitomycin c, Mitomycin-c, Mitomycine, Mitosol, Mitozytrex, Muamycin, Mutamycin

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Alkylating Drug
Mechanism of action
Alkylating Activity

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Mitomycin?

6 organisations hold an active US FDA Type II Drug Master File or a CEP for Mitomycin: CONCORD BIOTECH LTD (India), HUBEI HONCH PHARMACEUTICAL CO LTD, TAPI NL BV (Netherlands), Wuxi Fortune Pharmaceutical Co., Ltd. (China), Zhejiang Hisun Pharmaceutical Co., Ltd. (China) and CHEMWERTH INC (France). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Mitomycin Drug Master Files are active?

CONCORD BIOTECH LTD (DMF 33662), HUBEI HONCH PHARMACEUTICAL CO LTD (DMF 37462), TAPI NL BV (DMF 13791), Wuxi Fortune Pharmaceutical Co., Ltd. (DMF 34866), Zhejiang Hisun Pharmaceutical Co., Ltd. (DMF 13783, 25659) and CHEMWERTH INC (DMF 33811). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Mitomycin records mean?

2 organisations have only inactive Type II DMFs for Mitomycin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Mitomycin have a European Certificate of Suitability?

Yes. 5 organisations hold a valid CEP for Mitomycin on the EDQM register, including HUBEI HONCH PHARMACEUTICAL CO., LTD. Huanggang (CN), CONCORD BIOTECH LIMITED Ahmedabad (IN), TAPI NL B.V. Amsterdam (NL), WUXI FORTUNE PHARMACEUTICAL CO., LTD. Wuxi (CN) and Zhejiang Hisun Pharmaceutical Co., Ltd. Taizhou City (CN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Mitomycin?

Yes. The latest patent listed for an approved US product containing Mitomycin expires 25 Jul 2044, across 22 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Mitomycin supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Mitomycin?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.